A Complete Account of EMA Approvals in 2024

Shots: In 2024, EMA approved around 53 drugs in various therapy areas, ranging from cardiology, oncology, hematology, neurology, and dermatology to infectious diseases, vaccines, diagnostic agents, pneumology, nephrology, hepatology, ophthalmology, and endocrinology PharmaShots, in an illuminating report, brings a condensed analysis of the approved drugs with the most explored areas being Oncology, Hematology, Neurology, &…

ByDipanshu DixitMarch 6, 2025

TOP 20

20 Emerging Animal Health Companies of India

20 Emerging Animal Health Companies of India Shots: Owing to the agrarian origin and rise in pet ownership trends, the animal healthcare sector in India has witnessed a significant boom In 2023, the animal healthcare market size was valued at $1.9B and is anticipated to grow to $4.3B by 2030, registering a CAGR of 12.3%…

ByPrince GiriFebruary 10, 2025

TOP 20

20 Contract Development and Manufacturing Organizations (CDMO) of 2024

Shots: CDMOs are at the forefront of pharmaceutical manufacturing, shaping the industry's growth by meeting the increasing global demand for pharmaceutical products In 2023, the global CDMO market was valued at $224.86B, with projections to reach $465.14B by 2032, demonstrating a CAGR of 8.5% PharmaShots presents a comprehensive report on the 20 Contract Development and…

ByPrince GiriNovember 14, 2024

TOP 20

Top 20 Generic Pharma Companies of 2024

Shots: Known for delivering the same therapeutic benefits as its brand-name counterpart, it won't be an exaggeration to refer to generic drugs as modern-day advocates for health equity In 2022, the global market size of generic drugs was valued at $411.99B and is envisioned to reach $613.34B by 2030 with a CAGR of 5.10%. Sandoz…

ByPrince GiriSeptember 26, 2024

A Complete Account of EMA Approvals in 2024

20 Emerging Animal Health Companies of India

20 Contract Development and Manufacturing Organizations (CDMO) of 2024

Top 20 Generic Pharma Companies of 2024

Contact US

FOLLOW US